Israel’s Teva Pharmaceuticals will start to distribute a medical cannabis inhaler developed by Syqe, an Israeli start-up that raised money from tobacco giant Philip Morris. The inhaler may also be tested with opiates.
An editorial in The Scientist says its unacceptable that the World Health Organization has not developed positions on legalization.
Toronto’s Hospital for Sick Children will begin a clinical trial of cannabis extracts containing CBD and THC for children with severe epilepsy.
A new study from Steep Hill Labs found that 83 percent of California weed wouldn’t pass Oregon’s testing standards. An industry report says Oregon’s strict regulations are crushing the state industry. Willamette Week reports that business conditions are pushing some entrepreneurs back to the underground market.
Rehab provider Spectrum Health Systems said a doctor was not to blame for revealing to a patient’s employer that she uses MED.
A survey of cannabis researchers finds out what they want from the government in order to pursue their work.
A Reason investigation finds that conservative authorities in Idaho “conspired to restrict a promising cannabis-derived seizure treatment.”
The National Fire Protection Association is developing fire safety standards for cannabis businesses.
The FDA will allow a late stage clinical trial for ecstasy as a treatment for PTSD.
Minnessota approved PTSD as a MED qualifying condition. New York approved chronic pain.
Canada’s legalization push is getting complicated. The much-anticipated task force report on legalizationhas been delayed. Meanwhile activists wonder why shops are getting raided if the government plans to legalize. For more see here.
Bill Blair a Canadian government official overseeing the issue appeared at a “ cash-for-access” fundraiser with cannabiz leaders that may have violated Liberal Party ethics guidelines. Blair defended recent raidssaying, “The only system for control is the existing legal regime. And we’re a society of laws,” he says.
